オレンシア(アバタセプト)薬の世界市場:販売動向2018

【英語タイトル】Global Orencia (abatacept) Drug Sales Market Report 2018

QYResearchが出版した調査資料(QYR80709713)・商品コード:QYR80709713
・発行会社(調査会社):QYResearch
・発行日:2018年10月
・ページ数:101
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥856,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、オレンシア(アバタセプト)薬の世界市場について調査・分析し、オレンシア(アバタセプト)薬のメーカー別販売量、市場シェア分析、種類別販売分析(プレフィルドシリンジ、バイアル)、用途別販売分析(関節リウマチ、乾癬性関節炎、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、オレンシア(アバタセプト)薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・オレンシア(アバタセプト)薬市場概要
・オレンシア(アバタセプト)薬のメーカー別販売量・メーカー別シェア
・オレンシア(アバタセプト)薬の世界市場:種類別販売量(プレフィルドシリンジ、バイアル)
・オレンシア(アバタセプト)薬の世界市場:用途別販売量(関節リウマチ、乾癬性関節炎、その他)
・オレンシア(アバタセプト)薬の世界市場:地域別販売量・市場シェア
・オレンシア(アバタセプト)薬の米国市場規模
・オレンシア(アバタセプト)薬の中国市場規模
・オレンシア(アバタセプト)薬の欧州市場規模
・オレンシア(アバタセプト)薬の日本市場規模
・オレンシア(アバタセプト)薬の東南アジア市場規模
・オレンシア(アバタセプト)薬のインド市場規模
・オレンシア(アバタセプト)薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・オレンシア(アバタセプト)薬のコスト分析・価格動向
・オレンシア(アバタセプト)薬の産業チェーン(サプライチェーン分析)
・オレンシア(アバタセプト)薬のマーケティング戦略・販売チャネル、流通業者
・オレンシア(アバタセプト)薬市場への影響要因分析
・オレンシア(アバタセプト)薬の世界市場予測
・オレンシア(アバタセプト)薬の米国市場予測
・オレンシア(アバタセプト)薬の中国市場予測
・オレンシア(アバタセプト)薬の欧州市場予測
・オレンシア(アバタセプト)薬の日本市場予測
・オレンシア(アバタセプト)薬の東南アジア市場予測
・オレンシア(アバタセプト)薬のインド市場予測
・オレンシア(アバタセプト)薬の種類別世界市場予測(プレフィルドシリンジ、バイアル)
・オレンシア(アバタセプト)薬の用途別世界市場予測(関節リウマチ、乾癬性関節炎、その他)
...
【レポートの概要】

This report studies the global Orencia (abatacept) Drug market status and forecast, categorizes the global Orencia (abatacept) Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a modified antibody.
The global Orencia (abatacept) Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Bristol-Myers Squibb

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Prefilled Syringe
Vial
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Rheumatoid Arthritis
Psoriatic Arthritis
Other

The study objectives of this report are:
To analyze and study the global Orencia (abatacept) Drug sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Orencia (abatacept) Drug players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Orencia (abatacept) Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Orencia (abatacept) Drug Manufacturers
Orencia (abatacept) Drug Distributors/Traders/Wholesalers
Orencia (abatacept) Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Orencia (abatacept) Drug market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Orencia (abatacept) Drug Sales Market Report 2018
1 Orencia (abatacept) Drug Market Overview
1.1 Product Overview and Scope of Orencia (abatacept) Drug
1.2 Classification of Orencia (abatacept) Drug by Product Category
1.2.1 Global Orencia (abatacept) Drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Orencia (abatacept) Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Prefilled Syringe
1.2.4 Vial
1.3 Global Orencia (abatacept) Drug Market by Application/End Users
1.3.1 Global Orencia (abatacept) Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Rheumatoid Arthritis
1.3.2 Psoriatic Arthritis
1.3.3 Other
1.4 Global Orencia (abatacept) Drug Market by Region
1.4.1 Global Orencia (abatacept) Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Orencia (abatacept) Drug Status and Prospect (2013-2025)
1.4.3 Europe Orencia (abatacept) Drug Status and Prospect (2013-2025)
1.4.4 China Orencia (abatacept) Drug Status and Prospect (2013-2025)
1.4.5 Japan Orencia (abatacept) Drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Orencia (abatacept) Drug Status and Prospect (2013-2025)
1.4.7 India Orencia (abatacept) Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Orencia (abatacept) Drug (2013-2025)
1.5.1 Global Orencia (abatacept) Drug Sales and Growth Rate (2013-2025)
1.5.2 Global Orencia (abatacept) Drug Revenue and Growth Rate (2013-2025)

2 Global Orencia (abatacept) Drug Competition by Players/Suppliers, Type and Application
2.1 Global Orencia (abatacept) Drug Market Competition by Players/Suppliers
2.1.1 Global Orencia (abatacept) Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Orencia (abatacept) Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Orencia (abatacept) Drug (Volume and Value) by Type
2.2.1 Global Orencia (abatacept) Drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Orencia (abatacept) Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Orencia (abatacept) Drug (Volume and Value) by Region
2.3.1 Global Orencia (abatacept) Drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Orencia (abatacept) Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Orencia (abatacept) Drug (Volume) by Application

3 United States Orencia (abatacept) Drug (Volume, Value and Sales Price)
3.1 United States Orencia (abatacept) Drug Sales and Value (2013-2018)
3.1.1 United States Orencia (abatacept) Drug Sales and Growth Rate (2013-2018)
3.1.2 United States Orencia (abatacept) Drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Orencia (abatacept) Drug Sales Price Trend (2013-2018)
3.2 United States Orencia (abatacept) Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Orencia (abatacept) Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Orencia (abatacept) Drug Sales Volume and Market Share by Application (2013-2018)

4 Europe Orencia (abatacept) Drug (Volume, Value and Sales Price)
4.1 Europe Orencia (abatacept) Drug Sales and Value (2013-2018)
4.1.1 Europe Orencia (abatacept) Drug Sales and Growth Rate (2013-2018)
4.1.2 Europe Orencia (abatacept) Drug Revenue and Growth Rate (2013-2018)
4.1.3 Europe Orencia (abatacept) Drug Sales Price Trend (2013-2018)
4.2 Europe Orencia (abatacept) Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Orencia (abatacept) Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Orencia (abatacept) Drug Sales Volume and Market Share by Application (2013-2018)

5 China Orencia (abatacept) Drug (Volume, Value and Sales Price)
5.1 China Orencia (abatacept) Drug Sales and Value (2013-2018)
5.1.1 China Orencia (abatacept) Drug Sales and Growth Rate (2013-2018)
5.1.2 China Orencia (abatacept) Drug Revenue and Growth Rate (2013-2018)
5.1.3 China Orencia (abatacept) Drug Sales Price Trend (2013-2018)
5.2 China Orencia (abatacept) Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Orencia (abatacept) Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Orencia (abatacept) Drug Sales Volume and Market Share by Application (2013-2018)

6 Japan Orencia (abatacept) Drug (Volume, Value and Sales Price)
6.1 Japan Orencia (abatacept) Drug Sales and Value (2013-2018)
6.1.1 Japan Orencia (abatacept) Drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Orencia (abatacept) Drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Orencia (abatacept) Drug Sales Price Trend (2013-2018)
6.2 Japan Orencia (abatacept) Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Orencia (abatacept) Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Orencia (abatacept) Drug Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Orencia (abatacept) Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Orencia (abatacept) Drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Orencia (abatacept) Drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Orencia (abatacept) Drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Orencia (abatacept) Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Orencia (abatacept) Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Orencia (abatacept) Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Orencia (abatacept) Drug Sales Volume and Market Share by Application (2013-2018)

8 India Orencia (abatacept) Drug (Volume, Value and Sales Price)
8.1 India Orencia (abatacept) Drug Sales and Value (2013-2018)
8.1.1 India Orencia (abatacept) Drug Sales and Growth Rate (2013-2018)
8.1.2 India Orencia (abatacept) Drug Revenue and Growth Rate (2013-2018)
8.1.3 India Orencia (abatacept) Drug Sales Price Trend (2013-2018)
8.2 India Orencia (abatacept) Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Orencia (abatacept) Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Orencia (abatacept) Drug Sales Volume and Market Share by Application (2013-2018)

9 Global Orencia (abatacept) Drug Players/Suppliers Profiles and Sales Data
9.1 Bristol-Myers Squibb
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Orencia (abatacept) Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bristol-Myers Squibb Orencia (abatacept) Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview

10 Orencia (abatacept) Drug Maufacturing Cost Analysis
10.1 Orencia (abatacept) Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Orencia (abatacept) Drug
10.3 Manufacturing Process Analysis of Orencia (abatacept) Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Orencia (abatacept) Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Orencia (abatacept) Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Orencia (abatacept) Drug Market Forecast (2018-2025)
14.1 Global Orencia (abatacept) Drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Orencia (abatacept) Drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Orencia (abatacept) Drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Orencia (abatacept) Drug Price and Trend Forecast (2018-2025)
14.2 Global Orencia (abatacept) Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Orencia (abatacept) Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Orencia (abatacept) Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Orencia (abatacept) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Orencia (abatacept) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Orencia (abatacept) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Orencia (abatacept) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Orencia (abatacept) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Orencia (abatacept) Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Orencia (abatacept) Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Orencia (abatacept) Drug Sales Forecast by Type (2018-2025)
14.3.2 Global Orencia (abatacept) Drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Orencia (abatacept) Drug Price Forecast by Type (2018-2025)
14.4 Global Orencia (abatacept) Drug Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Orencia (abatacept) Drug
Figure Global Orencia (abatacept) Drug Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Orencia (abatacept) Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Prefilled Syringe Product Picture
Figure Vial Product Picture
Figure Global Orencia (abatacept) Drug Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Orencia (abatacept) Drug by Application in 2017
Figure Rheumatoid Arthritis Examples
Table Key Downstream Customer in Rheumatoid Arthritis
Figure Psoriatic Arthritis Examples
Table Key Downstream Customer in Psoriatic Arthritis
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Orencia (abatacept) Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Orencia (abatacept) Drug Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Orencia (abatacept) Drug Sales Volume (K Units) (2013-2018)
Table Global Orencia (abatacept) Drug Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Orencia (abatacept) Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Orencia (abatacept) Drug Sales Share by Players/Suppliers
Figure 2017 Orencia (abatacept) Drug Sales Share by Players/Suppliers
Figure Global Orencia (abatacept) Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Orencia (abatacept) Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Orencia (abatacept) Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Orencia (abatacept) Drug Revenue Share by Players
Table 2017 Global Orencia (abatacept) Drug Revenue Share by Players
Table Global Orencia (abatacept) Drug Sales (K Units) and Market Share by Type (2013-2018)
Table Global Orencia (abatacept) Drug Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Orencia (abatacept) Drug by Type (2013-2018)
Figure Global Orencia (abatacept) Drug Sales Growth Rate by Type (2013-2018)
Table Global Orencia (abatacept) Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Orencia (abatacept) Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Orencia (abatacept) Drug by Type (2013-2018)
Figure Global Orencia (abatacept) Drug Revenue Growth Rate by Type (2013-2018)
Table Global Orencia (abatacept) Drug Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Orencia (abatacept) Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Orencia (abatacept) Drug by Region (2013-2018)
Figure Global Orencia (abatacept) Drug Sales Growth Rate by Region in 2017
Table Global Orencia (abatacept) Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Orencia (abatacept) Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Orencia (abatacept) Drug by Region (2013-2018)
Figure Global Orencia (abatacept) Drug Revenue Growth Rate by Region in 2017
Table Global Orencia (abatacept) Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Orencia (abatacept) Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Orencia (abatacept) Drug by Region (2013-2018)
Figure Global Orencia (abatacept) Drug Revenue Market Share by Region in 2017
Table Global Orencia (abatacept) Drug Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Orencia (abatacept) Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Orencia (abatacept) Drug by Application (2013-2018)
Figure Global Orencia (abatacept) Drug Sales Market Share by Application (2013-2018)
Figure United States Orencia (abatacept) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure United States Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Orencia (abatacept) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table United States Orencia (abatacept) Drug Sales Volume (K Units) by Players (2013-2018)
Table United States Orencia (abatacept) Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Orencia (abatacept) Drug Sales Volume Market Share by Players in 2017
Table United States Orencia (abatacept) Drug Sales Volume (K Units) by Type (2013-2018)
Table United States Orencia (abatacept) Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Orencia (abatacept) Drug Sales Volume Market Share by Type in 2017
Table United States Orencia (abatacept) Drug Sales Volume (K Units) by Application (2013-2018)
Table United States Orencia (abatacept) Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Orencia (abatacept) Drug Sales Volume Market Share by Application in 2017
Figure Europe Orencia (abatacept) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Orencia (abatacept) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Orencia (abatacept) Drug Sales Volume (K Units) by Players (2013-2018)
Table Europe Orencia (abatacept) Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Orencia (abatacept) Drug Sales Volume Market Share by Players in 2017
Table Europe Orencia (abatacept) Drug Sales Volume (K Units) by Type (2013-2018)
Table Europe Orencia (abatacept) Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Orencia (abatacept) Drug Sales Volume Market Share by Type in 2017
Table Europe Orencia (abatacept) Drug Sales Volume (K Units) by Application (2013-2018)
Table Europe Orencia (abatacept) Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Orencia (abatacept) Drug Sales Volume Market Share by Application in 2017
Figure China Orencia (abatacept) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure China Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Orencia (abatacept) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table China Orencia (abatacept) Drug Sales Volume (K Units) by Players (2013-2018)
Table China Orencia (abatacept) Drug Sales Volume Market Share by Players (2013-2018)
Figure China Orencia (abatacept) Drug Sales Volume Market Share by Players in 2017
Table China Orencia (abatacept) Drug Sales Volume (K Units) by Type (2013-2018)
Table China Orencia (abatacept) Drug Sales Volume Market Share by Type (2013-2018)
Figure China Orencia (abatacept) Drug Sales Volume Market Share by Type in 2017
Table China Orencia (abatacept) Drug Sales Volume (K Units) by Application (2013-2018)
Table China Orencia (abatacept) Drug Sales Volume Market Share by Application (2013-2018)
Figure China Orencia (abatacept) Drug Sales Volume Market Share by Application in 2017
Figure Japan Orencia (abatacept) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Orencia (abatacept) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Orencia (abatacept) Drug Sales Volume (K Units) by Players (2013-2018)
Table Japan Orencia (abatacept) Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Orencia (abatacept) Drug Sales Volume Market Share by Players in 2017
Table Japan Orencia (abatacept) Drug Sales Volume (K Units) by Type (2013-2018)
Table Japan Orencia (abatacept) Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Orencia (abatacept) Drug Sales Volume Market Share by Type in 2017
Table Japan Orencia (abatacept) Drug Sales Volume (K Units) by Application (2013-2018)
Table Japan Orencia (abatacept) Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Orencia (abatacept) Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Orencia (abatacept) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Orencia (abatacept) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Orencia (abatacept) Drug Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Orencia (abatacept) Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Orencia (abatacept) Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Orencia (abatacept) Drug Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Orencia (abatacept) Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Orencia (abatacept) Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Orencia (abatacept) Drug Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Orencia (abatacept) Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Orencia (abatacept) Drug Sales Volume Market Share by Application in 2017
Figure India Orencia (abatacept) Drug Sales (K Units) and Growth Rate (2013-2018)
Figure India Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Orencia (abatacept) Drug Sales Price (USD/Unit) Trend (2013-2018)
Table India Orencia (abatacept) Drug Sales Volume (K Units) by Players (2013-2018)
Table India Orencia (abatacept) Drug Sales Volume Market Share by Players (2013-2018)
Figure India Orencia (abatacept) Drug Sales Volume Market Share by Players in 2017
Table India Orencia (abatacept) Drug Sales Volume (K Units) by Type (2013-2018)
Table India Orencia (abatacept) Drug Sales Volume Market Share by Type (2013-2018)
Figure India Orencia (abatacept) Drug Sales Volume Market Share by Type in 2017
Table India Orencia (abatacept) Drug Sales Volume (K Units) by Application (2013-2018)
Table India Orencia (abatacept) Drug Sales Volume Market Share by Application (2013-2018)
Figure India Orencia (abatacept) Drug Sales Volume Market Share by Application in 2017
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Orencia (abatacept) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Orencia (abatacept) Drug Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Orencia (abatacept) Drug Sales Global Market Share (2013-2018)
Figure Bristol-Myers Squibb Orencia (abatacept) Drug Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Orencia (abatacept) Drug
Figure Manufacturing Process Analysis of Orencia (abatacept) Drug
Figure Orencia (abatacept) Drug Industrial Chain Analysis
Table Raw Materials Sources of Orencia (abatacept) Drug Major Players in 2017
Table Major Buyers of Orencia (abatacept) Drug
Table Distributors/Traders List
Figure Global Orencia (abatacept) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Orencia (abatacept) Drug Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Orencia (abatacept) Drug Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Orencia (abatacept) Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Orencia (abatacept) Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Orencia (abatacept) Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Orencia (abatacept) Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Orencia (abatacept) Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Orencia (abatacept) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Orencia (abatacept) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Orencia (abatacept) Drug Revenue and Growth Rate Forecast (2018-2025)
Figure China Orencia (abatacept) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Orencia (abatacept) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Orencia (abatacept) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Orencia (abatacept) Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Orencia (abatacept) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Orencia (abatacept) Drug Sales (K Units) Forecast by Type (2018-2025)
Figure Global Orencia (abatacept) Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Orencia (abatacept) Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Orencia (abatacept) Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Orencia (abatacept) Drug Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Orencia (abatacept) Drug Sales (K Units) Forecast by Application (2018-2025)
Figure Global Orencia (abatacept) Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

オレンシア(アバタセプト)薬、プレフィルドシリンジ、バイアル、関節リウマチ、乾癬性関節炎

★調査レポート[オレンシア(アバタセプト)薬の世界市場:販売動向2018] (コード:QYR80709713)販売に関する免責事項を必ずご確認ください。
★調査レポート[オレンシア(アバタセプト)薬の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆